Brevan Howard Capital Management LP Iovance Biotherapeutics, Inc. Transaction History
Brevan Howard Capital Management LP
- $9.23 Billion
- Q1 2025
A detailed history of Brevan Howard Capital Management LP transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 107,615 shares of IOVA stock, worth $202,316. This represents 0.0% of its overall portfolio holdings.
Number of Shares
107,615
Previous 11,962
799.64%
Holding current value
$202,316
Previous $88,000
306.82%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding IOVA
# of Institutions
334Shares Held
247MCall Options Held
1.34MPut Options Held
1.61M-
Vanguard Group Inc Valley Forge, PA27.8MShares$52.2 Million0.0% of portfolio
-
Mhr Fund Management LLC New York, NY24.4MShares$45.9 Million12.15% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$39.9 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY12.7MShares$23.9 Million1.77% of portfolio
-
State Street Corp Boston, MA11MShares$20.8 Million0.0% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $297M
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...